Genetic changes in colorectal adenoma and cancer in relation to various morphologic aspects

Journal of Gastroenterology

Volumn 33, Issue 6, 1998, Pages 804-810

  Fujimori, Takahiro ^a   Ono, Yuko ^a   Sakuma, Kazuhiro ^a   Ueda, Yoshihiko ^a   Terano, Akira ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Genetic change; Tumor evolution

Indexed keywords

PROTEIN P53;

ADENOMA; BASE MISPAIRING; COLORECTAL CANCER; COLORECTAL TUMOR; DNA REPAIR; EARLY DIAGNOSIS; GENE MUTATION; HUMAN; METHYLATION; MICROADENOMA; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RNA SPLICING; TELOMERE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENES, P53; GENES, RAS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; SENSITIVITY AND SPECIFICITY;

EID: 0032450061     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050179     Document Type: Review

References (36)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319:525-532.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorgenesis. Cell 1990;61:759-767.
3. Banerjee AK. DCC expression and progression in colorectal cancer. Lancet 1997;349:968.
4. Shimoda T, Ikegami M, Fujisaki J, et al. Early colorectal carcinoma with special reference to its development de novo. Cancer 1989;64:1138-1146.
5. Fujimori T, Nagasako K, Satonaka K, et al. Expression of ras oncogene product (p-21) and point mutation of Ki-ras codon 12 in superficial early colorectal cancer. Stomach and Intestine (Tokyo) 1992;27:111-117.
6. Fujimori T, Satonaka K, Yamamura-Idei Y, et al. Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int J Cancer 1994;57:51-55.
7. Yamamura-Idei Y, Satonaka K, Fujimori T, et al. p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis. Dig Dis Sci 1994;39: 2043-2048.
8. Yukawa M, Fujimori T, Maeda S, et al. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut 1994; 35:1258-1261.
9. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-2270.
10. Roberts TM. A signal chain of events. Nature 1992;360:534-535.
11. Narumiya S. The small GTPase Rho: Cellular functions and signal transduction. J Biochem 1996;120:215-228.
12. Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997;275:1649-1652.
13. Iino H, Fukayama M, Maeda Y, et al. Molecular genetics for clinical management of colorectal carcinoma: 17p, 18q, a, d, 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994;73:1324-1331.
14. Shibata D, Reale MA, Lavin PL, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996;335:1727-1732.
15. Nobusawa R, et al. DCC gene codon 201Arg/Gly polymorphism in flat type colorectal tumors. Stomach and Intestine (Tokyo) 1995;30:207-212.
16. Tada S, Yao T, Iida M, et al. A clinicopathologic study of small flat colorectal carcinoma. Cancer 1994;74:2430-2435.
17. Kuramoto S, Oohara T. How does colorectal cancer develop? Cancer 1995;75:1534-1538.
18. Aoki T, Takeda S, Yanagisawa A, et al. APC and p53 mutation in de novo colorectal adenocarcinoma. Human Mutation 1994;3:342-346.
19. 716 knockout mice. Cancer Res 1997;57:1644-1649.
20. Otsuka M, Nagasako H, Sano Y, et al. Correlation between the intramucosal growth type and the incidence of p53-overexpression and point mutations of K-ras gene in the development of colorectal cancer less than 20mm in diameter. Gastroenterol Endosc 1997;39:779-785.
21. Kudo S, Hirota S, Nakajima T, et al. Colorectal tumors and pit pattern. J Clin Pathol 1994;47:880-885.
22. Sano Y, Fujimori T, Ichikawa K, et al. Comparative studies of the surface structure of colorectal tumor with its histological features. Stomach and Intestine (Tokyo) 1996;31:1327-1340.
23. Stout AP. Superficial spreading type of carcinoma of the stomach. Arch Surg 1942;44:651-657.
24. Nagasako H, Hasegawa K, Iizuka B, et al. Endoscopic study of colon polyps. Gastroenterol Surgery 1984;7:1393-1402.
25. Fujii T, Oda Y, Tamura S, et al. The features of clinicopathological and genetic background in lateral spreading colorectal tumor: Endoscopic diagnosis of the depth of invasion. Endosc Dig 1997;9:181-191.
26. Urbanski SJ, Macron N, Kossakowska AE, et al. Mixed hyperplastic adenomatous polyposis: An underdiagnosed entity. Am J Surg Pathol 1984;8:551-556.
27. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas: A distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-537.
28. Kang M, Sada M, Tokumitsu Y, et al. Ki-67, p53, and Bcl-2 of serrated adenomas of the colon. Am J Surg Pathol 1977;21:417-423.
29. Kubo K, Kato Y, Yanagisawa A, et al. Serrated adenoma. Endosc Dig 1997;9:559-563.
30. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen. Cancer Lett 1987;37:147-151.
31. Siu IM, Pretlow TG, Amini SB, et al. Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol 1997:1805-1813.
32. Roncucci L, Pedroni M, Fante R, et al. Cell kinetic evaluation of human colonic aberrant crypts. Cancer Res 1993;108:434-440.
33. Yamashita N, Minamoto T, Ochia A, et al. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of colon. Gastroenterology 1995;108:434-440.
34. Heinin CD, Shivapurkar N, Tang Z, et al. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 1996;56:5339-5341.
35. Watson AJM, DuBois RN. Lipid metabolism and APC: Implications for colorectal cancer prevention. Lancet 1997;349:444-445.
36. Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995;1:1245-1251.